WallStreetZenWallStreetZen

NASDAQ: ELEV
Elevation Oncology Inc Stock Ownership - Who owns Elevation Oncology?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Elevation Oncology Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2024-03-164,773$4.39
$20.95kSell
Tammy FurlongCHIEF FINANCIAL OFFICER2024-02-15403$2.77
$1.12kSell
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2023-12-164,773$0.51
$2.43kSell
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2023-09-164,773$0.73
$3.47kSell
Joseph J. Ferra Jr.INTERIM CEO CFO2023-06-164,773$1.47
$7.02kSell

1 of 1

ELEV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELEV insiders and whales buy or sell their stock.

ELEV Shareholders

What type of owners hold Elevation Oncology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Tang Capital Management LLC7.54%3,667,600$15.84MInstitution
Millennium Management LLC6.15%2,990,279$12.92MInstitution
Venbio Partners LLC5.99%2,914,255$12.59MInstitution
Aisling Capital Management LP5.83%2,834,910$12.25MInstitution
Aisling Capital Iv LP5.83%2,834,910$12.25MInsider
Qiming Us Healthcare Fund Ii LP4.87%2,370,142$10.24MInsider
Qiming Us Ventures Management LLC4.87%2,370,142$10.24MInstitution
Bvf Inc4.75%2,312,200$9.99MInstitution
Vertex Global Hc Fund Ii Pte Ltd4.74%2,307,642$9.97MInsider
Cormorant Asset Management LP4.59%2,233,168$9.65MInsider

1 of 3

ELEV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELEV53.13%24.22%Net SellingNet Selling
ATOS12.74%15.22%Net BuyingNet Buying
CRDF11.85%34.59%Net Buying
ABOS63.98%16.58%Net Buying
INMB12.71%40.66%Net BuyingNet Buying
View Top Biotech Stocks

Elevation Oncology Stock Ownership FAQ

Who owns Elevation Oncology?

Elevation Oncology (NASDAQ: ELEV) is owned by 53.13% institutional shareholders, 24.22% Elevation Oncology insiders, and 22.64% retail investors. Aisling Capital Iv LP is the largest individual Elevation Oncology shareholder, owning 2.83M shares representing 5.83% of the company. Aisling Capital Iv LP's Elevation Oncology shares are currently valued at $11.00M.

If you're new to stock investing, here's how to buy Elevation Oncology stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.